Proton pump inhibitors and 180-day mortality in the elderly after
Clostridium difficile
Enteric pathogens
Infectious disease
Medication safety
Proton pump inhibitors
Journal
Gut pathogens
ISSN: 1757-4749
Titre abrégé: Gut Pathog
Pays: England
ID NLM: 101474263
Informations de publication
Date de publication:
2019
2019
Historique:
received:
31
03
2019
accepted:
29
05
2019
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
19
6
2019
Statut:
epublish
Résumé
There is a reported association between proton pump inhibitor (PPI) exposure and increased risk of Of the 874 elderly adults treated for CDI, 180-day all-cause mortality was 12.4%. Exposure to a PPI was associated with a 55% reduced risk of mortality (adjusted hazard ratio (aHR) 0.45; 95% confidence interval (CI) 0.28-0.72). In our Cox model, increasing age (aHR 1.45; 95% CI 1.14-1.84), those with severe CDI infections (aHR 1.87; 95% CI 1.22-2.88), and those with hospital acquired CDI (aHR 3.01; 95% CI 1.81-4.99) also had increased 180 day mortality risk. There were similar associations noted with both 90 day and 1-year mortality. Use of PPIs during CDI treatment in elderly patients is associated with decreased 180-day mortality. Although use of PPIs has been associated with an increased risk of CDI, it appears to be protective against mortality when used during the treatment phase.
Sections du résumé
BACKGROUND
BACKGROUND
There is a reported association between proton pump inhibitor (PPI) exposure and increased risk of
RESULTS
RESULTS
Of the 874 elderly adults treated for CDI, 180-day all-cause mortality was 12.4%. Exposure to a PPI was associated with a 55% reduced risk of mortality (adjusted hazard ratio (aHR) 0.45; 95% confidence interval (CI) 0.28-0.72). In our Cox model, increasing age (aHR 1.45; 95% CI 1.14-1.84), those with severe CDI infections (aHR 1.87; 95% CI 1.22-2.88), and those with hospital acquired CDI (aHR 3.01; 95% CI 1.81-4.99) also had increased 180 day mortality risk. There were similar associations noted with both 90 day and 1-year mortality.
CONCLUSION
CONCLUSIONS
Use of PPIs during CDI treatment in elderly patients is associated with decreased 180-day mortality. Although use of PPIs has been associated with an increased risk of CDI, it appears to be protective against mortality when used during the treatment phase.
Identifiants
pubmed: 31210787
doi: 10.1186/s13099-019-0309-6
pii: 309
pmc: PMC6563367
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
QJM. 2000 Mar;93(3):175-81
pubmed: 10751237
Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:74-81
pubmed: 10807407
Clin Infect Dis. 2007 Nov 1;45(9):1141-51
pubmed: 17918075
World J Gastroenterol. 2008 Jul 21;14(27):4338-41
pubmed: 18666322
Am J Gastroenterol. 2008 Sep;103(9):2308-13
pubmed: 18702653
Gastroenterology. 2010 Jan;138(1):82-8
pubmed: 19837071
BMJ. 2011 May 11;342:d2690
pubmed: 21562004
Can J Gastroenterol. 2011 Jul;25(7):368-72
pubmed: 21876858
Clin Infect Dis. 2011 Dec;53(12):1173-8
pubmed: 21976459
Am J Gastroenterol. 2012 Jul;107(7):1011-9
pubmed: 22525304
Mayo Clin Proc. 2012 Jul;87(7):636-42
pubmed: 22766083
Evid Based Ment Health. 2013 Nov;16(4):95
pubmed: 23939678
Am J Gastroenterol. 2013 Nov;108(11):1794-801
pubmed: 24060760
PLoS One. 2014 Jun 04;9(6):e98400
pubmed: 24897375
Surgery. 2014 Oct;156(4):972-8
pubmed: 25151556
PLoS One. 2014 Oct 24;9(10):e110790
pubmed: 25343667
Biol Pharm Bull. 2014;37(11):1811-5
pubmed: 25366486
Infect Control Hosp Epidemiol. 2015 Feb;36(2):132-41
pubmed: 25632995
Infect Dis Clin North Am. 2015 Mar;29(1):123-34
pubmed: 25677706
N Engl J Med. 2015 Feb 26;372(9):825-34
pubmed: 25714160
Clin Infect Dis. 2015 May 15;60 Suppl 2:S66-71
pubmed: 25922403
Ann Pharmacother. 2015 Sep;49(9):1004-8
pubmed: 26139638
Gut. 2016 May;65(5):740-8
pubmed: 26657899
Am J Gastroenterol. 2016 Nov;111(11):1641-1648
pubmed: 27575714
Expert Opin Drug Saf. 2016 Dec;15(12):1589-1595
pubmed: 27645304
Gastroenterology. 2017 Mar;152(4):706-715
pubmed: 28257716
Infect Dis Clin North Am. 2017 Dec;31(4):743-756
pubmed: 29079158
J Am Geriatr Soc. 2018 Feb;66(2):333-338
pubmed: 29120481
Intensive Care Med. 2018 Jan;44(1):1-11
pubmed: 29199388
Kidney Int Rep. 2017 Nov 10;3(2):374-384
pubmed: 29725641
Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171
pubmed: 29732377
Antimicrob Resist Infect Control. 2018 Jun 15;7:75
pubmed: 29946450
Arch Intern Med. 1986 Jan;146(1):95-100
pubmed: 3942469
Clin Ther. 1996 Jan-Feb;18(1):2-34; discussion 1
pubmed: 8851451